1-(Fmoc-amino)-4-methyl-cyclohex-3-ene-1-carboxylic acid, 99.0%, 250mg

Methyl 4-iodopyridine-2-carboxylate, 95.0%, 1g

1,3,2-Dioxaborolane, 4,4,5,5-tetramethyl-2-[(1E)-2-(trimethylsilyl)ethenyl]-, 95%, 100mg

N-Methyl-N-tetrahydro-2H-pyran-4ylamine, 97.0%, 10g

4-Bromoquinoline-8-carboxylic acid, 98%, 100mg

(S)-2-((S)-2-((tert-Butoxycarbonyl)amino)-4-methylpentanamido)-4-methylpentanoic acid, 95.0%, 25g

tert-Butyl 3-(2-methoxy-2-oxoethyl)morpholine-4-carboxylate, 95.0%, 250mg

3-hydroxy-1,3-bis(naphthalen-2-yl)prop-2-en-1-one, 97%, 250mg

Sodium ((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogenphosphate, 98.0%, 1g

ROTI®Elutionsgefäße MIDI 3.5, 50-800 µl, 100 Stück

Fmoc-3-(1-Naphthyl)-alanine, >99%, 1g

3-nitropyridin-4-ol 1-oxide, 5g

(4-Bromo-2-(trifluoromethyl)phenyl)boronic acid, 97%, 250mg